Discovery of common molecular signatures and drug repurposing for COVID-19/Asthma comorbidity: ACE2 and multi-partite networks

J Xu, R Abdulsalam Khaleel, HK Zaidan… - Cell Cycle, 2024 - Taylor & Francis
ABSTRACT Angiotensin-converting enzyme 2 (ACE2) is identified as the functional receptor
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of …

[HTML][HTML] Effect of Hydroxychloroquine and Azithromycin Combination Use in COVID-19 Patients–An Umbrella Review

K Nag, K Tripura, A Datta, N Karmakar… - Indian Journal of …, 2024 - journals.lww.com
Background: Hydroxychloroquine and Azithromycin combination was used rampantly in
management of COVID-19 patients in different countries. Present review was conducted to …

Chloroquine Up-regulates Expression of SARS-CoV-2 receptor Angiotensin Converting Enzyme-2 in Endothelial Cells

HC Nguyen, S Bu, L Wang, A Singh, KK Singh - bioRxiv, 2024 - biorxiv.org
Background and Purpose: The novel severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) posed a serious threat to global public health. Hydroxychloroquine (HCQ) …

[HTML][HTML] Knowledge, attitude and prevalence of ivermectin use as coronavirus disease treatment: A crosssectional study among a Malaysian population

AJA Amanina, NANS Hadi - … physician: the official journal of the …, 2024 - ncbi.nlm.nih.gov
Methods: This cross-sectional study was conducted among 391 Malaysians aged≥ 18
years. A validated online self-administered questionnaire disseminated via Google Forms …

[PDF][PDF] Knowledge, attitude and prevalence of ivermectin use as coronavirus disease treatment: A cross-sectional study among a Malaysian population

FNA Tar'ali, AAA Jalil… - Malaysian Family …, 2024 - scienceopen.com
Introduction: During the coronavirus disease (COVID-19) pandemic, there was a widespread
public misconception regarding ivermectin use in managing the disease. ere is no approval …